These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27141764)

  • 1. Top 10 Facts You Need to Know about Pneumococcal Vaccination in Adults.
    Rehman T; Khan ZS
    J Miss State Med Assoc; 2016 Feb; 57(2):32-4. PubMed ID: 27141764
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 3. 13-valent pneumococcal vaccine: 50 years of age and older.
    Prescrire Int; 2013 Feb; 22(135):38. PubMed ID: 23444498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering Guidelines on the Use of Pneumococcal Vaccines in Adults 65 Years or Older.
    Hochman M; Cohen PA
    JAMA Intern Med; 2015 Dec; 175(12):1895-6. PubMed ID: 26502317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccination against pneumococcal infection in adults].
    Viejo JL
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():26-8. PubMed ID: 20084346
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
    Kenzel S; Hufnagel M; Berner R; Henneke P
    Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
    [No Abstract]   [Full Text] [Related]  

  • 7. Nurse-led vaccination program dramatically improves pneumococcal vaccination coverage among patients with autoimmune inflammatory disorders.
    Serre J; François C; der Haegen MCV; Papo T; Goulenok T; Sacre K
    Eur J Intern Med; 2017 Sep; 43():e43-e45. PubMed ID: 28552464
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions].
    Picazo JJ; González-Romo F; García Rojas A; Peréz-Trallero E; Gil Gregorio P; de la Cámara R; Morató ML; Rodríguez A; Barberán J; Domínguez Hernández V; Linares Rufo M; Jimeno Sanz I; Portolés JM; Sanz Herrero F; Espinosa Arranz J; García-Sánchez V; Galindo Izquierdo M
    Rev Esp Quimioter; 2013 Sep; 26(3):232-52. PubMed ID: 24080892
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumococcal vaccination: effective in children under the age of 2 years.
    Prescrire Int; 2009 Dec; 18(104):266. PubMed ID: 20027709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of pneumococcal disease among adults.
    Maxim RB
    Med Health R I; 2001 May; 84(5):174-5. PubMed ID: 11392959
    [No Abstract]   [Full Text] [Related]  

  • 11. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 4. Health care for the elderly and vaccination: Current situation of pneumococcal vaccines and pneumococcal diseases].
    Oishi K
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2247-51. PubMed ID: 27522786
    [No Abstract]   [Full Text] [Related]  

  • 12. Influenza and pneumococcal vaccination: how far we have come and how to go farther.
    Wu HM; Abrutyn E
    Infect Control Hosp Epidemiol; 2004 Nov; 25(11):901-3. PubMed ID: 15566020
    [No Abstract]   [Full Text] [Related]  

  • 13. Can vaccination prevent sinusitis?
    Conrad DA
    Postgrad Med; 2004 Jan; 115(1):33-4. PubMed ID: 14755874
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving Pneumococcal Immunization Rates Among Hospitalized Adults.
    Schurlknight M
    Nurs Econ; 2015; 33(3):182-5. PubMed ID: 26259344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.
    Jiang Y; Gauthier A; Keeping S; Carroll S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):913-27. PubMed ID: 25189087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal vaccination in asthma.
    Rees PJ
    Int J Clin Pract; 2006 Nov; 60(11):1341-2. PubMed ID: 17073831
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumococcal polysaccharide vaccines do not protect the elderly from pneumococcal infections.
    Lipsky BA; Hirschmann JV
    Neth J Med; 2004 Feb; 62(2):33-5. PubMed ID: 15127828
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients.
    Forstner C; Plefka S; Tobudic S; Winkler HM; Burgmann K; Burgmann H
    Vaccine; 2012 Aug; 30(37):5449-52. PubMed ID: 22749594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium.
    Blommaert A; Bilcke J; Willem L; Verhaegen J; Goossens H; Beutels P
    Vaccine; 2016 Apr; 34(18):2106-12. PubMed ID: 26988257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.